Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
Status:
Completed
Trial end date:
2017-02-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DCVAC/PCa added onto Standard of Care
therapy can improve survival times for patients with Metastatic Castration Resistant Prostate
Cancer